Le Lézard
Classified in: Health, Business
Subjects: CCA, FVT

The Cigna Group's Fourth Quarter 2023 Earnings Release Details


BLOOMFIELD, Conn., Jan. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2023 financial results on Friday, February 2, 2024, and will host a conference call the same day.

Fourth quarter 2023 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows:

Live Call
(888) 566-1889 (Domestic)
(773) 799-3989 (International)
Passcode: 2022024

Replay
(800) 839-9317 (Domestic)
(203) 369-3605 (International)

It is strongly suggested that participants dial in to the conference call by 8:15 a.m. ET on February 2. A replay of the call will be available from 12:30 p.m. ET on February 2 until 11:59 p.m. ET on February 16, 2023. Additionally, the conference call will be available on a live internet webcast at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Group's website. Please note that this feature will be in listen-only mode.

A copy of the company's news release and financial supplement will be available on The Cigna Group's website in the Investor Relations section at https://investors.thecignagroup.com/overview/default.aspx, no later than 6:30 a.m. ET on February 2.

About The Cigna Group
The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 countries and jurisdictions, and has approximately 165 million customer relationships around the world. Learn more at thecignagroup.com.

Investor Relations Contact
Ralph Giacobbe
1 (860) 787-7968
[email protected]

Media Contact
Justine Sessions
1 (860) 810-6523
[email protected]

SOURCE The Cigna Group


These press releases may also interest you

at 01:00
IONETIC boosts British battery plans with global Rockwell Automation collaboration
Rockwell Automation, Inc. , the world's largest company dedicated to industrial automation and digital transformation, today announced a new multi-year, global partnership with IONETIC, a UK startup dedicated to making EV batteries affordable for...

at 01:00
Cyber insurtech BOXX partners with Zurich Insurance Group in Switzerland to introduce breakthrough personal cyber product
Award-winning global Insurtech BOXX Insurance Inc. that combines cyber insurance and security has announced the launch of a cutting-edge cyber risk solution in collaboration with Zurich Insurance Group in Switzerland, providing digital protection for...

at 00:45
PropertyGuru Reports First Quarter 2024 Results
PropertyGuru Group Limited ("PropertyGuru" or the "Company"), Southeast Asia's leading1, property technology ("PropTech") company, today announced financial results for the quarter ended March 31, 2024. Revenue of S$37 million in the first quarter...

at 00:15
THE BRADFORD EXCHANGE MINT HONORS THE 80TH ANNIVERSARY OF D-DAY
The Bradford Exchange Mint, source for coins of enduring value worldwide, announces an extraordinary tribute to the "Greatest Generation" heroes as we mark the 80th anniversary of D-Day. D-Day ? 6 June 1944 ? over 150,000 heroic Allied forces from...

at 00:01
U.S. News Releases the 2024-2025 Best Places to Live Rankings
U.S. News & World Report, the global authority in rankings and consumer advice, today unveiled the 2024-2025 Best Places to Live in the U.S. The new list ranks 150 major U.S. cities based on value, desirability, job market and quality of life....

at 00:00
Astellas Announces a Collaboration with YASKAWA to Create an Innovative Cell Therapy Ecosystem through the Integration of Pharmaceutical and Robotics Technologies
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it signed a memorandum of understanding with YASKAWA Electric Corporation (YASKAWA) to begin discussions on the creation of an innovative cell therapy...

More news about Business...


News published on and distributed by: